Health AI Central
Share:
Peer-Reviewed Publication
Epigenomics2023;15(16):805-818.August 1, 2023Journal Article

Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally.

Damon Broyles1,2, Robert Philibert3,4,5
1Mercy Technology Services, St. Louis, MO 63127, USA.
2Mercy Precision Medicine, Chesterfield, MO 63017, USA.
3Department of Psychiatry, University of Iowa, Iowa City, IA 52242, USA.
4Cardio Diagnostics Inc, Chicago, IL 60642, USA.
5Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
PubMed DOI

Abstract

Coronary heart disease (CHD) is the world's leading cause of death. Up to 90% of all CHD deaths are preventable, but effective prevention of this mortality requires more scalable, precise methods for assessing CHD status and monitoring treatment response. Unfortunately, current diagnostic methods have barriers to implementation, particularly in rural areas and lower-income countries. This gap may…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.